Comparison of blood and tumor clearance of 123I-scFvD2B with data obtained previously with 131I-scFvD2B [16] suggested an improvement due to a clear trend toward a shorter circulatory half-life and a longer retention in PSMA-positive tumors. Here, FOLH1 is linked to neoplasm.